ABOUT

Transforming Vision Care Through Genetics

eyegx dna bl
+
Total Years of Experience
+
R&D Team Members
%
Satisfied Customer
+
Winning Awards

Who We Are

Dedicated to Innovative Solutions in Eye Health and Genetics

EyeGx is pioneering a first-of-its-kind, PCR genetic test designed for complete eye health insight. Powered by our digital-first AI platform, it brings genetics into everyday vision care helping detect risk factors for dozens of common and serious eye conditions before symptoms appear. Beyond detection, EyeGx transforms results into precise vitamin and supplement recommendations, delivered through a seamless, personalized platform to help protect and preserve your sight.

GAkDjgq2rneG4lz 8r0 768x1024

Our Journey

The Evolution of EyeGx and Its Vision

Founded by a team of vision care experts, EyeGx was established to harness the potential of genetic testing in eye health. With breakthroughs in AI and our partnership with national institutes, we have developed an innovative platform that continues to lead in precision medicine, transforming patient care since our inception.

Optometrist 1024x599

Our PURPOSE

Research & Development

Developed in collaboration with the National Eye Institute’s eyeGENE® program, EyeGx is built on years of genomic medicine research and clinical validation. The platform uses a multiplex PCR genetic panel targeting 20+ high-value genes associated with conditions such as glaucoma, age-related macular degeneration, retinitis pigmentosa, cataracts, and myopia.

Each variant is matched to evidence-based nutritional interventions like lutein for macular health or magnesium for glaucoma support through seamless integration with the Nymara AI system. This combination of cutting-edge genetics, targeted supplementation, and AI-driven interpretation positions EyeGx at the forefront of precision eye health, bridging the gap between early detection, actionable prevention, and the emerging frontiers of gene therapy, AI diagnostics, and national vision preservation efforts.

Scroll to Top